Results 291 to 300 of about 222,471 (336)

Impact of a multicomponent intervention on maternal Tdap vaccination coverage during a major pertussis resurgence in the province of Quebec, Canada: A quasi-experimental study. [PDF]

Hum Vaccin Immunother
Kamgang PG, Beauregard MÈ, Zhou Z, Kiely M, Brousseau N.   +4 more
europepmc   +1 more source

A Glucose‐Responsive Intelligent Antibacterial and Oxygen‐Producing Hydrogel Promotes the Healing of Diabetic Wounds by Regulating Cellular Heterogeneity

Advanced Science, EarlyView.
We have developed a glucose‐triggered on‐demand drug delivery CF‐CPGaMPN hydrogel based on borate ester bonds. It inactivates microbes, releases oxygen, and enables on‐demand drug release in high‐glucose environments to promote healing of diabetic wounds. Single‐cell sequencing reveals that the CF‐CPGaMPN hydrogel significantly alleviates dysfunctional
Manxuan Liu, Zhongcheng Li, Qian Ren, Ziqian Lu, Yubing Zhang, Yili Guo, Ruomeng Li, Die Hu, Linglin Zhang   +8 more
wiley   +1 more source

Vaccination Coverage in Hematopoietic Stem Cell Transplant Patients. [PDF]

Vaccines (Basel)
Bouzas-Rodríguez A, Molina-Romera G, Vázquez-Lago JM, Vázquez-Cancela O, Fernández-Pérez C.   +4 more
europepmc   +1 more source

Corrigendum to “Beyond coverage: Rural-urban disparities in the timeliness of childhood vaccinations in Tanzania” [Vaccine 40(37) (2022) 5483–5493]

Valerie Yelverton, Nicole L. Hair, Suvomita Happy Ghosh, Sayoki Mfinanga, Esther Ngadaya, Joy Noel Baumgartner, Jan Ostermann, Lavanya Vasudevan   +7 more
openalex   +1 more source

SMart Nanoparticle–Hydrogel Hybrid System for Synergistic Eradication of Infection and Promotion of Wound Healing

Advanced Science, EarlyView.
The integrated system, comprising bacterial‐targeted photothermal nanoparticles (Fe2O3‐CS@RBP) and multifunctional hydrogels (PAOC‐3@BA) modules, achieves rapid wound healing within one week. This work introduces a smart therapeutic platform that integrates bacterial targeting, self‐regulating photothermal therapy, tissue adhesion, and stimulus ...
Hongping Wan, Huirong Tan, Xinghong Zhao
wiley   +1 more source

Maternal Vaccination Coverage in Brazil From 2018 to 2022: A Cross-Sectional Descriptive Analysis Using Minimum and Maximum Estimates. [PDF]

Cureus
Barbosa Carvalho do Carmo C, de Lima Pereira L.   +1 more
europepmc   +1 more source

Non‐Targeting shRNA‐Encoded Plasmid DNA Enhances Protective Immunity Through RIDD‐RIG‐I Signaling Pathway in the Zika Virus Animal Model

Advanced Science, EarlyView.
We present a novel DNA vaccine platform featuring intrinsic, non‐targeting dsRNA that significantly enhances immune responses by activating the regulated IRE1‐dependent decay‐RIG‐I signaling pathway. This research elucidates a previously uncharacterized mechanism for dsRNA‐mediated innate immune activation.
Min‐Syuan Huang, Hung‐Chun Liao, Po Peng, Wan‐Ling Wu, Kit Man Chai, Mei‐Yu Chen, Guann‐Yi Yu, Tsung‐Hsien Chuang, Hsin‐Wei Chen, Chuang‐Rung Chang, Shih‐Jen Liu   +10 more
wiley   +1 more source

Tetanus toxoid vaccination coverage and associated factors among pregnant women in East Africa: systematic review and meta-analysis. [PDF]

BMC Public Health
Taye BA, Weldearegay BY, Yirsaw BG, Belete AK.   +3 more
europepmc   +1 more source

MARPLE: A Proximity‐Triggered CRISPR‐Cas13 Platform for Ultrasensitive Antibody Detection

Advanced Science, EarlyView.
MARPLE is a modular CRISPR‐Cas13 immunoassay that uses antibody‐induced proximity to trigger a toehold‐exchange reaction, releasing an RNA activator for Cas13. This one‐pot, isothermal architecture enables ultrasensitive (femtomolar) and highly specific detection of diverse antibodies, including therapeutic, pathogen‐specific, and cancer‐associated ...
Elena Spezzani, Luca Capelli, Denise Di Lena, Alejandro Chamorro‐Garcia, Rudy Ippodrino, Alessandro Porchetta, Alessandro Bertucci   +6 more
wiley   +1 more source

Human Papillomavirus Vaccination Coverage Estimates Among the Primary Target Cohort (9-14-Year-Old Girls) in the World (2010-2024). [PDF]

Vaccines (Basel)
Ilic I, Ilic M.
europepmc   +1 more source